This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 5 from Patent US 20120302729
General Information
DRACP ID DRACP01417
Peptide Name Sequence 5 from Patent US 20120302729
Sequence QDLFGRAPSKAVNPDEA
Sequence Length 17
UniProt ID Q5R511 O35501 Q3ZCH0 P38647 P48721 Q5ZM98 P38646
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C78H123N23O27
Absent amino acids CHIMTWY
Common amino acids A
Mass 210055
Pl 4.37
Basic residues 2
Acidic residues 3
Hydrophobic residues 6
Net charge -1
Boman Index -4199
Hydrophobicity -82.94
Aliphatic Index 57.65
Half Life
Mammalian: 5.5 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2012/0302729 A1
Patent Title Anticancer anti-mortalin peptide antibody.
Other Iinformation Granted Patent Family: 8s / 8ex; Family Jurisdictions: EP, US, WO, JP; Legal Status: Inactive; Application No: 201013514755; Filed:Dec 9, 2010; Published: Nov 29, 2012; Earliest Priority: Dec 10, 2009; Granted: Nov 19, 2013
Other Published ID EP2511371A1 EP2511371A4
This work is licensed under a Creative Commons Attribution 4.0 International License.